8. Ulrichs T, Moody DB, Grant E, Kaufmann SH, Porcelli SA (2003) T-cell responses to CD1-presented lipid antigens in humans with Mycobacterium tuberculosis infection. Infect Immun 71: 3076–3087. 9. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, et al. (1994) Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 372: 691–694. 10. Sieling PA, Chatterjee D, Porcelli SA, Prigozy TI, Mazzaccaro RJ, et al. (1995) CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269: 227–230. 11. Moody DB, Reinhold BB, Guy MR, Beckman EM, Frederique DE, et al. (1997) Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 278: 283–286. 12. Gilleron M, Stenger S, Mazorra Z, Wittke F, Mariotti S, et al. (2004) Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J Exp Med 199: 649–659. 13. Matsunaga I, Bhatt A, Young DC, Cheng TY, Eyles SJ, et al. (2004) Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T cells. J Exp Med 200: 1559–1569. 14. Moody DB, Young DC, Cheng TY, Rosat JP, Roura-Mir C, et al. (2004) T cell activation by lipopeptide antigens. Science 303: 527–531. 15. Spinozzi F, Porcelli SA (2007) Recognition of lipids from pollens by CD1- restricted T cells. Immunol Allergy Clin North Am 27: 79–92. 16. Shamshiev A, Donda A, Carena I, Mori L, Kappos L, et al. (1999) Self glycolipids as T-cell autoantigens. Eur J Immunol 29: 1667–1675. 17. Sieling PA, Porcelli SA, Duong BT, Spada F, Bloom BR, et al. (2000) Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c. J Immunol 165: 5338–5344. 18. Dascher CC, Brenner MB (2003) Evolutionary constraints on CD1 structure: insights from comparative genomic analysis. Trends Immunol 24: 412–418. 19. Miller MM, Wang C, Parisini E, Coletta RD, Goto RM, et al. (2005) Characterization of two avian MHC-like genes reveals an ancient origin of the CD1 family. Proc Natl Acad Sci U S A 102: 8674–8679. 20. Van Kaer L (2007) NKT cells: T lymphocytes with innate effector functions. Curr Opin Immunol 19: 354–364. 21. Yu KO, Porcelli SA (2005) The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy. Immunol Lett 100: 42–55. 22. Gumperz JE, Miyake S, Yamamura T, Brenner MB (2002) Functionally Distinct Subsets of CD1d-restricted Natural Killer T Cells Revealed by CD1d Tetramer Staining. J Exp Med 195: 625–636. 23. Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, et al. (2000) Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 192: 741–754. 24. Chiu YH, Jayawardena J, Weiss A, Lee D, Park SH, et al. (1999) Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J Exp Med 189: 103–110. 25. Chiu YH, Park SH, Benlagha K, Forestier C, Jayawardena-Wolf J, et al. (2002) Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nat Immunol 3: 55–60. 26. Chen X, Wang X, Keaton JM, Reddington F, Illarionov PA, et al. (2007) Distinct endosomal trafficking requirements for presentation of autoantigens and exogenous lipids by human CD1d molecules. J Immunol 178: 6181–6190. 27. Christiansen D, Milland J, Mouhtouris E, Vaughan H, Pellicci DG, et al. (2008) Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation. PLoS Biol 6: e172. 28. Zhou D, Mattner J, Cantu C, 3rd, Schrantz N, Yin N, et al. (2004) Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1786–1789. 29. Fox LM, Cox DG, Lockridge JL, Wang X, Chen X, et al. (2009) Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol 7: e1000228. 30. Lan P, Tonomura N, Shimizu A, Wang S, Yang YG (2006) Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood 108: 487–492. The CD1 System in Humanized Mice 31. Rajesh D, Zhou Y, Jankowska-Gan E, Roenneburg DA, Dart ML, et al. (2010) Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rgamma- mice. Hum Immunol 71: 551–559. 32. Wei DG, Lee H, Park SH, Beaudoin L, Teyton L, et al. (2005) Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes. J Exp Med 202: 239–248. 33. Chun T, Page MJ, Gapin L, Matsuda JL, Xu H, et al. (2003) CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells. J Exp Med 197: 907–918. 34. Exley M, Garcia J, Wilson SB, Spada F, Gerdes D, et al. (2000) CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes. Immunology 100: 37–47. 35. Moody DB, Briken V, Cheng TY, Roura-Mir C, Guy MR, et al. (2002) Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation. Nat Immunol 3: 435–442. 36. Wang X, Chen X, Rodenkirch L, Simonson W, Wernimont S, et al. (2008) Natural killer T-cell autoreactivity leads to a specialized activation state. Blood 112: 4128–4138. 37. Prigozy TI, Naidenko O, Qasba P, Elewaut D, Brossay L, et al. (2001) Glycolipid antigen processing for presentation by CD1d molecules. Science 291: 664–667. 38. Porcelli S, Brenner MB, Greenstein JL, Balk SP, Terhorst C, et al. (1989) Recognition of cluster of differentiation 1 antigens by human CD4-CD8- cytolytic T lymphocytes. Nature 341: 447–450. 39. Spada FM, Grant EP, Peters PJ, Sugita M, Melian A, et al. (2000) Self- recognition of CD1 by gamma/delta T cells: Implications for innate immunity. J Exp Med 191: 937–948. 40. Vincent MS, Xiong X, Grant EP, Peng W, Brenner MB (2005) CD1a-, b-, and c-restricted TCRs recognize both self and foreign antigens. J Immunol 175: 6344–6351. 41. de Lalla C, Lepore M, Piccolo FM, Rinaldi A, Scelfo A, et al. (2011) High- frequency and adaptive-like dynamics of human CD1 self-reactive T cells. Eur J Immunol 41: 602–610. 42. de Jong A, Pena-Cruz V, Cheng TY, Clark RA, Van Rhijn I, et al. (2010) CD1a-autoreactive T cells are a normal component of the human alphabeta T cell repertoire. Nat Immunol 11: 1102–1109. 43. Rymarchyk SL, Lowenstein H, Mayette J, Foster SR, Damby DE, et al. (2008) Widespread natural variation in murine natural killer T-cell number and function. Immunology 125: 331–343. 44. Kenna T, O’Brien M, Hogan AE, Exley MA, Porcelli SA, et al. (2007) CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver. Cancer Immunol Immunother 56: 563–572. 45. Durante-Mangoni E, Wang R, Shaulov A, He Q, Nasser I, et al. (2004) Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells. J Immunol 173: 2159–2166. 46. Kita H, Naidenko OV, Kronenberg M, Ansari AA, Rogers P, et al. (2002) Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 123: 1031–1043. 47. Osman Y, Kawamura T, Naito T, Takeda K, Van Kaer L, et al. (2000) Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide. Eur J Immunol 30: 1919–1928. 48. Rosat JP, Grant EP, Beckman EM, Dascher CC, Sieling PA, et al. (1999) CD1- restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. J Immunol 162: 366–371. 49. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB (2003) Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 4: 1230–1237. 50. de Jong A, Arce EC, Cheng TY, van Summeren RP, Feringa BL, et al. (2007) CD1c presentation of synthetic glycolipid antigens with foreign alkyl branching motifs. Chem Biol 14: 1232–1242. 51. Yu KO, Im JS, Molano A, Dutronc Y, Illarionov PA, et al. (2005) Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha- galactosylceramides. Proc Natl Acad Sci U S A 102: 3383–3388. 52. Lozzio BB, Lozzio CB (1979) Properties and usefulness of the original K-562 human myelogenous leukemia cell line. Leuk Res 3: 363–370. PLoS ONE | www.plosone.org 16 June 2011 | Volume 6 | Issue 6 | e21701